🚀 VC round data is live in beta, check it out!

enVVeno Medical Valuation Multiples

Discover revenue and EBITDA valuation multiples for enVVeno Medical and similar public comparables like Bioretec, Pheton Holdings, Carmat, BibbInstruments and more.

enVVeno Medical Overview

About enVVeno Medical

enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.


Founded

1999

HQ

United States

Employees

37

Financials (FY)

Revenue:
EBITDA: ($20M)

Market Cap

$8M

Valuation Multiples

Multiples.vc

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

enVVeno Medical Financials

enVVeno Medical reported last fiscal year revenue of — and negative EBITDA of ($20M).

In the same fiscal year, enVVeno Medical generated ($20M) in EBITDA losses and had net loss of ($19M).

Revenue (LTM)


enVVeno Medical P&L

In the most recent fiscal year, enVVeno Medical reported revenue of and EBITDA of ($20M).

enVVeno Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX

See enVVeno Medical forward-looking valuation multiples
LTMNTMLast FYFY 2026FY 2027FY 2028
EBITDAXXX($20M)XXXXXXXXX
Net ProfitXXX($19M)XXXXXXXXX

Financial data powered by Morningstar, Inc.

enVVeno Medical Stock Performance

enVVeno Medical has current market cap of $8M.

Market Cap Evolution


enVVeno Medical's stock price is $11.70.

See enVVeno Medical trading valuation data
Market CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$8M0.0%XXXXXXXXX$-29.70

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

enVVeno Medical Valuation Multiples

enVVeno Medical trades at 1.0x EV/EBITDA.

See valuation multiples for enVVeno Medical and 15K+ public comps

EV / Revenue (LTM)


enVVeno Medical Financial Valuation Multiples

As of April 20, 2026, enVVeno Medical has market cap of $8M.

Equity research analysts estimate enVVeno Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

enVVeno Medical has a P/E ratio of (0.4x).

LTMNTMLast FYFY 2026FY 2027FY 2028
Market cap (current)$8MXXX$8MXXXXXXXXX
EV (current)($20M)XXX($20M)XXXXXXXXX
EV/EBITDAXXX1.0xXXXXXXXXX
EV/EBITXXX0.9xXXXXXXXXX
P/EXXX(0.4x)XXXXXXXXX
EV/FCFXXX1.3xXXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified enVVeno Medical Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

enVVeno Medical Margins & Growth Rates

enVVeno Medical's revenue in the last fiscal year grew by .

enVVeno Medical's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.6M for the same period.

See operational valuation multiples for enVVeno Medical and other 15K+ public comps

enVVeno Medical Operational Valuation Multiples

LTMNTMLast FYFY 2026FY 2027FY 2028
EBITDA GrowthXXX(12%)XXXXXXXXX
Revenue per EmployeeXXX$0.0MXXXXXXXXX
Opex per EmployeeXXX$0.6MXXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

enVVeno Medical Public Comps

See public comps and valuation multiples for other Medical Devices comps.

EV/RevenueEV/EBITDA
LTM2026E2027ELTM2026E2027E
enVVeno MedicalXXXXXXXXXXXXXXXXXX
BioretecXXXXXXXXXXXXXXXXXX
Pheton HoldingsXXXXXXXXXXXXXXXXXX
CarmatXXXXXXXXXXXXXXXXXX
BibbInstrumentsXXXXXXXXXXXXXXXXXX
ZynexXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX

Valuation data powered by FactSet, Inc.

enVVeno Medical M&A Activity

enVVeno Medical acquired XXX companies to date.

Last acquisition by enVVeno Medical was on XXXXXXXX, XXXXX. enVVeno Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See M&A valuation multiples

Latest Acquisitions by enVVeno Medical

Acquired CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.

Start Free Trial

enVVeno Medical Investment Activity

enVVeno Medical invested in XXX companies to date.

enVVeno Medical made its latest investment on XXXXXXXX, XXXXX. enVVeno Medical invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See VC round multiples

Latest Investments by enVVeno Medical

CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About enVVeno Medical

When was enVVeno Medical founded?enVVeno Medical was founded in 1999.
Where is enVVeno Medical headquartered?enVVeno Medical is headquartered in United States.
How many employees does enVVeno Medical have?As of today, enVVeno Medical has over 37 employees.
Who is the CEO of enVVeno Medical?enVVeno Medical's CEO is Robert A. Berman.
Is enVVeno Medical publicly listed?Yes, enVVeno Medical is a public company listed on Nasdaq.
What is the stock symbol of enVVeno Medical?enVVeno Medical trades under NVNO ticker.
When did enVVeno Medical go public?enVVeno Medical went public in 2018.
Who are competitors of enVVeno Medical?enVVeno Medical main competitors are Bioretec, Pheton Holdings, Carmat, BibbInstruments.
What is the current market cap of enVVeno Medical?enVVeno Medical's current market cap is $8M.
Is enVVeno Medical profitable?No, enVVeno Medical is not profitable.

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial